Ferrous carbonate: Difference between revisions
Rabin Bista (talk | contribs) Created page with "{{DrugProjectFormSinglePage |aOrAn=a |indicationType=treatment |hasBlackBoxWarning=Yes |adverseReactions=<!--Black Box Warning--> |blackBoxWarningTitle=<span style="color:#FF0..." |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{DrugProjectFormSinglePage | {{DrugProjectFormSinglePage | ||
|authorTag={{RB}} | |||
|OTC=Yes | |||
|genericName=Ferrous carbonate | |||
|aOrAn=a | |aOrAn=a | ||
|drugClass=iron mineral | |||
|indicationType=treatment | |indicationType=treatment | ||
| | |indication=digestive complaints, and shyness | ||
|adverseReactions=<!--Black Box Warning--> | |adverseReactions=stomach upset, constipation or diarrhea, nausea, and vomiting | ||
<!--Black Box Warning--> | |||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
Line 12: | Line 20: | ||
<!--FDA-Labeled Indications and Dosage (Adult)--> | <!--FDA-Labeled Indications and Dosage (Adult)--> | ||
|fdaLIADAdult====== | |fdaLIADAdult=====Indications==== | ||
* For temporary relief of digestive complaints. Help with shyness. May also be used for standard homeopathic indications or as directed by your physician. | |||
* | |||
====Dosage==== | |||
* Place globules under tongue for 30 seconds. Adults~3-5 globules 3 times a day. Children 2-12 years ~ 1-3 | |||
globules 3 times a day. Under 2 years, consult your doctor. Use until symptoms are relieved or as directed by your health care provider. | |||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
==== | |||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Non–Guideline-Supported Use (Adult)--> | <!--Non–Guideline-Supported Use (Adult)--> | ||
|offLabelAdultNoGuideSupport= | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Pediatric Indications and Dosage--> | <!--Pediatric Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | <!--FDA-Labeled Indications and Dosage (Pediatric)--> | ||
|fdaLIADPed====== | |fdaLIADPed=====Indications==== | ||
* For temporary relief of digestive complaints. Help with shyness. May also be used for standard homeopathic indications or as directed by your physician. | |||
* | |||
==== | ====Dosage==== | ||
* Place globules under tongue for 30 seconds. Adults~3-5 globules 3 times a day. Children 2-12 years ~ 1-3 | |||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | globules 3 times a day. Under 2 years, consult your doctor. Use until symptoms are relieved or as directed by your health care provider. | ||
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Non–Guideline-Supported Use (Pediatric)--> | <!--Non–Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedNoGuideSupport= | |offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Contraindications--> | <!--Contraindications--> | ||
Line 113: | Line 49: | ||
<!--Warnings--> | <!--Warnings--> | ||
|warnings=* | |warnings=* Consult your health care provider if symptoms persist more than 5 days or worsen. | ||
* Keep out of the reach of children. | |||
* | |||
<!--Adverse Reactions--> | <!--Adverse Reactions--> | ||
<!--Clinical Trials Experience--> | <!--Clinical Trials Experience--> | ||
|clinicalTrials=There is limited information regarding | |clinicalTrials=There is limited information regarding the clinical trail experience | ||
|postmarketing=* stomach upset, constipation or diarrhea, nausea, and vomiting | |||
|drugInteractions= | |||
|postmarketing= | |||
|drugInteractions= | |||
<!--Use in Specific Populations--> | <!--Use in Specific Populations--> | ||
|useInPregnancyFDA=* | |useInPregnancyFDA=* If pregnant or breastfeeding ask a health professional before use. | ||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | ||
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | |useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | ||
|useInNursing= | |useInNursing=* If pregnant or breastfeeding ask a health professional before use. | ||
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients. | |useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients. | ||
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients. | |useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients. | ||
Line 264: | Line 76: | ||
<!--Administration and Monitoring--> | <!--Administration and Monitoring--> | ||
|administration=* | |administration=* sublingual | ||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |||
<!--IV Compatibility--> | <!--IV Compatibility--> | ||
Line 275: | Line 85: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|overdose= | |overdose=There is limited information regarding <i>Overdose</i> of {{PAGENAME}} in the drug label. | ||
There is limited information regarding <i> | |||
<!--Pharmacology--> | <!--Pharmacology--> |
Revision as of 16:50, 20 April 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Ferrous carbonate is a iron mineral that is FDA approved for the treatment of digestive complaints, and shyness. Common adverse reactions include stomach upset, constipation or diarrhea, nausea, and vomiting.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- For temporary relief of digestive complaints. Help with shyness. May also be used for standard homeopathic indications or as directed by your physician.
Dosage
- Place globules under tongue for 30 seconds. Adults~3-5 globules 3 times a day. Children 2-12 years ~ 1-3
globules 3 times a day. Under 2 years, consult your doctor. Use until symptoms are relieved or as directed by your health care provider.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Ferrous carbonate in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Ferrous carbonate in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Indications
- For temporary relief of digestive complaints. Help with shyness. May also be used for standard homeopathic indications or as directed by your physician.
Dosage
- Place globules under tongue for 30 seconds. Adults~3-5 globules 3 times a day. Children 2-12 years ~ 1-3
globules 3 times a day. Under 2 years, consult your doctor. Use until symptoms are relieved or as directed by your health care provider.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Ferrous carbonate in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Ferrous carbonate in pediatric patients.
Contraindications
- Condition1
Warnings
- Consult your health care provider if symptoms persist more than 5 days or worsen.
- Keep out of the reach of children.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding the clinical trail experience
Postmarketing Experience
- stomach upset, constipation or diarrhea, nausea, and vomiting
Drug Interactions
There is limited information regarding Ferrous carbonate Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- If pregnant or breastfeeding ask a health professional before use.
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Ferrous carbonate in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Ferrous carbonate during labor and delivery.
Nursing Mothers
- If pregnant or breastfeeding ask a health professional before use.
Pediatric Use
There is no FDA guidance on the use of Ferrous carbonate with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Ferrous carbonate with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Ferrous carbonate with respect to specific gender populations.
Race
There is no FDA guidance on the use of Ferrous carbonate with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Ferrous carbonate in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Ferrous carbonate in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Ferrous carbonate in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Ferrous carbonate in patients who are immunocompromised.
Administration and Monitoring
Administration
- sublingual
Monitoring
There is limited information regarding Monitoring of Ferrous carbonate in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Ferrous carbonate in the drug label.
Overdosage
There is limited information regarding Overdose of Ferrous carbonate in the drug label.
Pharmacology
There is limited information regarding Ferrous carbonate Pharmacology in the drug label.
Mechanism of Action
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Ferrous carbonate in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Ferrous carbonate in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Ferrous carbonate in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Ferrous carbonate in the drug label.
How Supplied
Storage
There is limited information regarding Ferrous carbonate Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Ferrous carbonate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Ferrous carbonate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Ferrous carbonate in the drug label.
Precautions with Alcohol
- Alcohol-Ferrous carbonate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Page Name=Ferrous carbonate |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Ferrous carbonate |Label Name=Ferrous carbonate11.png
}}
{{#subobject:
|Label Page=Ferrous carbonate |Label Name=Ferrous carbonate11.png
}}